BioMedExperts a Premier Online Scientific Social Network Community

Collexis Holdings, Inc.Dell and Collexis Holdings, Inc., plan to launch today BioMedExperts - an innovative social networking community that will promote collaborative medical research and development. BioMedExperts will allow health care and life sciences professionals to easily connect and collaborate with each other, as well as conduct research by providing 1.4 million biomedical experts with 12 million pre-established network connections from more than 120 countries. The site also provides the ability to analyze all associated professional connections within the network and view scientific publications.

As part of the initiative, Dell will provide computer hardware to power the Collexis-designed BioMedExperts. Dell will also provide marketing support for BioMedExperts, including co-branded marketing efforts and promotions at major life science research conferences.

"Dell believes connecting biomedical scientists through online communities will drive true innovation and progress and is critical to the future of biomedical research. BioMedExperts is a cutting-edge tool that can link researchers from around the globe and enable this new level of collaboration," said James Coffin, Ph.D., vice president and general manager, Dell Health Care and Life Sciences. "The Collexis technology and the BioMedExperts professional community is an example of how technology can connect scientists, enabling them to attack new and more complex cross-disciplinary biological problems. This next-generation professional network platform is a prime example of how Dell works with the world’s most innovative technology companies to drive thought leadership and leading-edge research collaboration."

Bill Kirkland, CEO of Collexis, said, "Collexis is excited about working with an industry leader like Dell, which has an intense focus on success in the life sciences market. We are also delighted to have their support in raising awareness of BioMedExperts among the growing number of biomedical researchers and health care providers who are finding online communities to be a perfect way to share, collaborate and discuss their work and discover new research opportunities. And we see this tool becoming even more valuable to researchers as we add millions of profiles during the next couple of months."

For further information, please visit:
http://www.biomedexperts.com

Related news articles:

About Dell
Dell Inc. (NASDAQ: DELL) listens to customers and delivers innovative technology and services they trust and value. Uniquely enabled by its direct business model, Dell is a leading global systems and services company and No. 34 on the Fortune 500. For more information, visit www.dell.com.

About Collexis Holdings, Inc.
Named a Trend-Setting product of 2007 by KMWorld, Collexis Holdings, Inc., a leading developer of high definition search and knowledge discovery software since 1999, is headquartered in Columbia, South Carolina (USA), with three subsidiaries: Collexis Inc. in Columbia, South Carolina, USA; Collexis, B.V. in Geldermalsen, The Netherlands; and SyynX Solutions GmBH in Cologne, Germany. Collexis proprietary technology builds conceptual profiles of text, called Fingerprints, from documents, websites, e-mails and other digitized content and matches them with a comprehensive list of pre-defined “fingerprinted” concepts to make research results more relevant and efficient. This matching of concepts eliminates the ambiguity and lack of priority associated with word searches. The results are often described as “finding needles in many haystacks.” Through this novel approach, Collexis can build unique applications to search, index and aggregate information as well as prioritize, trend and predict data based on sources in multiple industries without the limitations of language or dialect. Collexis’s current clients in the public, private and academic sectors include the Mayo Clinic; Johns Hopkins University; University of California, San Francisco; University of South Carolina; Erasmus University Library; Merck & Co.; Bristol-Myers Squibb; Lockheed Martin; the World Health Organization; Wellcome Trust; the National Institutes of Health; and the U.S. Department of Defense. Collexis shares of common stock are traded under the symbol CLXS on the OTC Bulletin Board (OTC BB). For more information, please visit www.collexis.com.

Most Popular Now

AI Catches One-Third of Interval Breast …

An AI algorithm for breast cancer screening has potential to enhance the performance of digital breast tomosynthesis (DBT), reducing interval cancers by up to one-third, according to a study published...

Great plan: Now We need to Get Real abou…

The government's big plan for the 10 Year Health Plan for the NHS laid out a big role for delivery. However, the Highland Marketing advisory board felt the missing implementation...

Researchers Create 'Virtual Scienti…

There may be a new artificial intelligence-driven tool to turbocharge scientific discovery: virtual labs. Modeled after a well-established Stanford School of Medicine research group, the virtual lab is complete with an...

From WebMD to AI Chatbots: How Innovatio…

A new research article published in the Journal of Participatory Medicine unveils how successive waves of digital technology innovation have empowered patients, fostering a more collaborative and responsive health care...

AI also Assesses Dutch Mammograms Better…

AI is detecting tumors more often and earlier in the Dutch breast cancer screening program. Those tumors can then be treated at an earlier stage. This has been demonstrated by...

RSNA AI Challenge Models can Independent…

Algorithms submitted for an AI Challenge hosted by the Radiological Society of North America (RSNA) have shown excellent performance for detecting breast cancers on mammography images, increasing screening sensitivity while...

AI could Help Emergency Rooms Predict Ad…

Artificial intelligence (AI) can help emergency department (ED) teams better anticipate which patients will need hospital admission, hours earlier than is currently possible, according to a multi-hospital study by the...

Head-to-Head Against AI, Pharmacy Studen…

Students pursuing a Doctor of Pharmacy degree routinely take - and pass - rigorous exams to prove competency in several areas. Can ChatGPT accurately answer the same questions? A new...

NHS Active 10 Walking Tracker Users are …

Users of the NHS Active 10 app, designed to encourage people to become more active, immediately increased their amount of brisk and non-brisk walking upon using the app, according to...

New AI Tool Illuminates "Dark Side…

Proteins sustain life as we know it, serving many important structural and functional roles throughout the body. But these large molecules have cast a long shadow over a smaller subclass...

The Human Touch of Doctors will Still be…

AI-based medicine will revolutionise care including for Alzheimer’s and diabetes, predicts a technology expert, but it must be accessible to all patients. Healing with Artificial Intelligence, written by technology expert Daniele...

Deep Learning-Based Model Enables Fast a…

Stroke is the second leading cause of death globally. Ischemic stroke, strongly linked to atherosclerotic plaques, requires accurate plaque and vessel wall segmentation and quantification for definitive diagnosis. However, conventional...